Sci Rep. 2025 Oct 8;15(1):35186.doi: 10.1038/s41598-025-19169-2.

中文速读

本研究针对胶质母细胞瘤,使用T98和U87细胞系,通过Entranster-R4000转染siRNA敲低PD-L1,研究PD-L1通过GP130/JAK2/STAT3/IRAK2/IL6通路促进肿瘤细胞增殖、迁移和侵袭。

体外(细胞)siRNAT98U87

本文使用:小核酸转染试剂Entranster™-R4000

查看产品详情(含全部 223 篇文献) →

PD-L1 autoregulation promotes the proliferation, migration and invasion of glioblastoma cells via GP130/JAK2/STAT3/IRAK2/IL6 signaling pathway

Affiliations

Affiliations

  • 1 Key Laboratory of Endemic and Ethnic Diseases, Ministry of Education, School of Basic Medical Science, Guizhou Medical University, Guiyang, 550004, Guizhou, China.
  • 2 Department of Pathology, Guizhou Provincial People’s Hospital, Guizhou University, Guiyang, 550002, Guizhou, China.
  • 3 The Second Hospital of Tianjin Medical University, Tianjin, 300211, China.
  • 4 Guizhou Provincial Staff Hospital, Guiyang, 550025, Guizhou, China.
  • 5 The Second People’s Hospital of Guiyang, Guiyang, 550081, Guizhou, China.
  • 6 Key Laboratory of Human Brain Bank for Functions and Diseases of Department of Education of Guizhou Province, College of Basic Medical, Guizhou Medical University, Guiyang, 550025, China.
  • 7 The Second Affiliated Hospital of Guizhou, University of Traditional Chinese Medicine, Guiyang, 550002, Guizhou, China.
  • 8 Department of Pathology, Guizhou Provincial People’s Hospital, Guizhou University, Guiyang, 550002, Guizhou, China. Yiwei6253@sina.com.
  • 9 Department of Neurology, Wulong District People’s Hospital, Wulong, Chongqing, 408500, China. 842031616@qq.com.
  • 10 Medical Laboratory Center, The Third Affiliated Hospital of Guizhou Medical University, Duyun, 558000, Guizhou, China. 842031616@qq.com.
  • 11 Key Laboratory of Endemic and Ethnic Diseases, Ministry of Education, School of Basic Medical Science, Guizhou Medical University, Guiyang, 550004, Guizhou, China. 1507295114@qq.com.
  • 12 Guizhou Provincial Key Laboratory of Pathogenesis and Drug Research on Common Chronic Diseases, Guiyang, 550004, Guizhou, China. 1507295114@qq.com.

Abstract

Glioblastoma (GBM) cells mediate immunosuppressive microenvironment, leading to poor response to programmed death-ligand 1(PD-L1) inhibitor therapy. How PD-L1 in GBM cells confers to GBM immunosuppressive microenvironment remains unclear. Here, we demonstrate that PD-L1 activated GP130/JAK2/STAT3/IRAK2/NFκB/IL6 pathway. We showed that PD-L1 was elevated in human primary GBM and promoted GBM cell viability, migration and invasion via activating janus kinase 2(JAK2) by interacting with glycoprotein 130(GP130) and PD-1 in GBM cells, leading to the activation of signal transducer and activator of transcription 3 (STAT3), a master that renders GBM immunosuppression. Overexpressing STAT3 reversed the effect of silencing PD-L1-mediated cell viability, proliferation, migration and invasion. STAT3 promoted interleukin-1 receptor-associated kinase 2(IRAK2) transcription. IRAK2 overexpression rescued the effect of silencing STAT3-mediated cell viability, proliferation, migration and invasion. Additionally, IRAK2 facilitated interleukin-6 (IL6) expression via activating nuclear factor kappa-B (NFκB). Our results indicate that PD-L1/GP130/JAK2/STAT3/IRAK2/NFκB/IL6 axis promotes GBM cell viability, proliferation, migration and invasion via interacting with GP130 and PD-1 in GBM cells. Additionally, STAT3 transcriptionally promoted PD-L1 expression, thus forming loops to lead to PD-L1 autoregulation. IL6 positively correlated with GBM-associated macrophages, myeloid-derived suppressor cells and the inhibition of dendritic cells. Our study suggests that PD-L1 autoregulation may create immunosuppressive GBM via activating GP130/JAK2/STAT3/IRAK2/IL-6 pathway.

Keywords: GP130; Glioblastoma; IL6; IRAK2; PD-L1; STAT3.

本文使用的产品

小核酸转染试剂Entranster™-R4000

已有 223 篇已发表文献

查看产品详情(含全部 223 篇文献) →

热线电话
  • 010-60535354
微信客服二维码 微信扫一扫,加微信客服
0
0
我的购物车
购物车是空的去下单